US Patent Issued to Glycomine on July 28 for "Liposomal formulations, and methods of using and preparing thereof" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,131, issued on July 28, was assigned to Glycomine Inc. (San Carlos, Calif.).

"Liposomal formulations, and methods of using and preparing thereof" was invented by Agnes Rafalko (San Francisco), Teppei Shirakura (San Bruno, Calif.) and Samuel Eric Greenberg (Los Gatos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides phosphorylated carbohydrate replacement therapies (CRT) that include compositions of phosphorylated carbohydrates and phospholipids, as well as methods for preparing such compositions. Such compositions are suitable for pharmaceutical delivery of phosphorylated carbohydrates to cell interior, endoplasmic retic...